The effectiveness of current treatments for breast cancer depends largely on the expression of hormone receptors for estrogen (ER), progesterone (PR), or the overexpression/amplification of human epidermal growth factor receptor-2 (HER2). Here, ERBB2 is linked to breast carcinoma.